Perrigo Company plc Financing Cash Flow
Perrigo Company plc (PRGO) reported Financing Cash Flow of -$434.20 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- Perrigo Company plc net cash provided by (used in) financing activities for the quarter ending 2026-06-27 was -$388.90M.
- Perrigo Company plc net cash provided by (used in) financing activities for the quarter ending 2026-03-28 was -$45.30M.
- Perrigo Company plc net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$54.40M.
- Perrigo Company plc net cash provided by (used in) financing activities for the quarter ending 2025-09-27 was -$50.30M, a 107.70% decline year-over-year.
- Perrigo Company plc net cash provided by (used in) financing activities for fiscal 2025 was -$220.50M.
- Perrigo Company plc net cash provided by (used in) financing activities for fiscal 2024 was -$611.00M.
- Perrigo Company plc net cash provided by (used in) financing activities for fiscal 2023 was -$187.20M, a 144.40% decline from fiscal 2022.
- Perrigo Company plc net cash provided by (used in) financing activities for fiscal 2022 was $421.60M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-27 | -$388.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$434.20M 10-Q · filed 2026-08-05 | -$488.60M derived: sum of 3 quarters · filed 2026-08-05 | -$538.90M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-28 | -$45.30M 10-Q · filed 2026-05-06 | -$99.70M derived: sum of 2 quarters · filed 2026-05-06 | -$150.00M derived: sum of 3 quarters · filed 2026-05-06 | -$204.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$54.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$104.70M derived: sum of 2 quarters · filed 2026-02-26 | -$158.70M derived: sum of 3 quarters · filed 2026-08-05 | -$220.50M 10-K · filed 2026-02-26 | ||||
| 2025-09-27 | -$50.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$104.30M derived: sum of 2 quarters · filed 2026-08-05 | -$166.10M 10-Q · filed 2025-11-05 | -$1.32B derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-28 | -$54.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$115.80M 10-Q · filed 2026-08-05 | -$1.27B derived: sum of 3 quarters · filed 2026-08-05 | -$616.60M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-29 | -$61.80M 10-Q · filed 2026-05-06 | -$1.22B derived: sum of 2 quarters · filed 2026-05-06 | -$562.60M derived: sum of 3 quarters · filed 2026-05-06 | -$612.40M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$1.15B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$500.80M derived: sum of 2 quarters · filed 2026-02-26 | -$550.60M derived: sum of 3 quarters · filed 2026-02-26 | -$611.00M 10-K · filed 2026-02-26 | ||||
| 2024-09-28 | $653.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $603.50M derived: sum of 2 quarters · filed 2025-11-05 | $543.10M 10-Q · filed 2025-11-05 | $498.50M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-29 | -$49.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$110.20M 10-Q · filed 2025-08-06 | -$154.80M derived: sum of 3 quarters · filed 2026-02-26 | -$198.10M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-30 | -$60.40M 10-Q · filed 2025-05-07 | -$105.00M derived: sum of 2 quarters · filed 2026-02-26 | -$148.30M derived: sum of 3 quarters · filed 2026-02-26 | -$196.90M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$44.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$87.90M derived: sum of 2 quarters · filed 2026-02-26 | -$136.50M derived: sum of 3 quarters · filed 2026-02-26 | -$187.20M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | -$43.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$91.90M derived: sum of 2 quarters · filed 2024-11-06 | -$142.60M 10-Q · filed 2024-11-06 | -$185.10M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-07-01 | -$48.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$99.30M 10-Q · filed 2024-08-02 | -$141.80M derived: sum of 3 quarters · filed 2025-02-28 | -$184.80M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-04-01 | -$50.70M 10-Q · filed 2024-05-07 | -$93.20M derived: sum of 2 quarters · filed 2025-02-28 | -$136.20M derived: sum of 3 quarters · filed 2025-02-28 | $422.80M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | -$42.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$85.50M derived: sum of 2 quarters · filed 2025-02-28 | $473.50M derived: sum of 3 quarters · filed 2025-02-28 | $421.60M 10-K · filed 2025-02-28 | ||||
| 2022-10-01 | -$43.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $516.00M derived: sum of 2 quarters · filed 2023-11-07 | $464.10M 10-Q · filed 2023-11-07 | $406.10M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-07-02 | $559.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $507.10M 10-Q · filed 2023-08-08 | $449.10M derived: sum of 3 quarters · filed 2024-02-27 | $412.80M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-04-02 | -$51.90M 10-Q · filed 2023-05-09 | -$109.90M derived: sum of 2 quarters · filed 2024-02-27 | -$146.20M derived: sum of 3 quarters · filed 2024-02-27 | -$187.30M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | -$58.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$94.30M derived: sum of 2 quarters · filed 2024-02-27 | -$135.40M derived: sum of 3 quarters · filed 2024-02-27 | -$178.70M 10-K · filed 2024-02-27 | ||||
| 2021-10-02 | -$36.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$77.40M derived: sum of 2 quarters · filed 2022-11-08 | -$120.70M 10-Q · filed 2022-11-08 | -$322.10M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-07-03 | -$41.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$84.40M 10-Q · filed 2022-08-09 | -$285.80M derived: sum of 3 quarters · filed 2023-02-28 | -$932.30M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-04-03 | -$43.30M 10-Q · filed 2022-05-11 | -$244.70M derived: sum of 2 quarters · filed 2023-02-28 | -$891.20M derived: sum of 3 quarters · filed 2023-02-28 | -$289.10M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | -$201.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$847.90M derived: sum of 2 quarters · filed 2023-02-28 | -$245.80M derived: sum of 3 quarters · filed 2023-02-28 | -$181.10M 10-K · filed 2023-02-28 | ||||
| 2020-09-26 | -$646.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$44.40M derived: sum of 2 quarters · filed 2021-11-12 | $20.30M 10-Q · filed 2021-11-12 | -$11.20M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-27 | $602.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $666.80M 10-Q · filed 2021-08-11 | $635.30M derived: sum of 3 quarters · filed 2022-03-01 | $490.40M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-28 | $64.70M 10-Q · filed 2021-05-12 | $33.20M derived: sum of 2 quarters · filed 2022-03-01 | -$111.70M derived: sum of 3 quarters · filed 2022-03-01 | $108.10M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | -$31.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$176.40M derived: sum of 2 quarters · filed 2022-03-01 | $43.40M derived: sum of 3 quarters · filed 2022-03-01 | $1.80M 10-K · filed 2022-03-01 | ||||
| 2019-09-28 | -$144.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $74.90M derived: sum of 2 quarters · filed 2020-11-05 | $33.30M 10-Q · filed 2020-11-05 | -$1.00M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-29 | $219.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $178.20M 10-Q · filed 2020-08-05 | $143.90M derived: sum of 3 quarters · filed 2021-03-01 | -$31.50M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-30 | -$41.60M 10-Q · filed 2020-05-05 | -$75.90M derived: sum of 2 quarters · filed 2021-03-01 | -$251.30M derived: sum of 3 quarters · filed 2021-03-01 | -$450.90M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | -$34.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$209.70M derived: sum of 2 quarters · filed 2021-03-01 | -$409.30M derived: sum of 3 quarters · filed 2021-03-01 | -$571.90M 10-K · filed 2021-03-01 | ||||
| 2018-09-29 | -$175.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$375.00M derived: sum of 2 quarters · filed 2019-11-06 | -$537.60M 10-Q · filed 2019-11-06 | -$921.30M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | -$199.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$362.20M 10-Q · filed 2019-08-08 | -$745.90M derived: sum of 3 quarters · filed 2020-02-27 | -$918.40M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$162.60M 10-Q · filed 2019-05-09 | -$546.30M derived: sum of 2 quarters · filed 2020-02-27 | -$718.80M derived: sum of 3 quarters · filed 2020-02-27 | -$3.13B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | -$383.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$556.20M derived: sum of 2 quarters · filed 2020-02-27 | -$2.97B derived: sum of 3 quarters · filed 2020-02-27 | -$3.00B 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | -$172.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$2.58B derived: sum of 2 quarters · filed 2018-11-08 | -$2.62B 10-Q · filed 2018-11-08 | -$2.66B derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-07-01 | -$2.41B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$2.45B 10-Q · filed 2018-08-09 | -$2.48B derived: sum of 3 quarters · filed 2019-02-27 | -$3.02B derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-04-01 | -$37.20M 10-Q · filed 2018-05-08 | -$71.80M derived: sum of 2 quarters · filed 2019-02-27 | -$611.40M derived: sum of 3 quarters · filed 2019-02-27 | -$743.30M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | -$34.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$574.20M derived: sum of 2 quarters · filed 2019-02-27 | -$706.10M derived: sum of 3 quarters · filed 2019-02-27 | -$268.70M 10-K · filed 2019-02-27 | ||||
| 2016-10-01 | -$539.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$671.50M derived: sum of 2 quarters · filed 2017-11-09 | -$234.10M 10-Q · filed 2017-11-09 | -$128.20M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-07-02 | -$131.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $305.50M 10-Q · filed 2017-08-10 | $411.40M derived: sum of 3 quarters · filed 2018-03-01 | $455.10M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-04-02 | $437.40M 10-Q · filed 2017-05-30 | $449.00M 10-Q · filed 2016-05-16 | $543.30M derived: sum of 2 quarters · filed 2018-03-01 | $587.00M derived: sum of 3 quarters · filed 2018-03-01 | -$368.20M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $105.90M derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-01 | $149.60M 10-K · filed 2018-03-01 | $193.60M 10-KT · filed 2016-02-25 | -$805.60M derived: sum of 3 quarters · filed 2018-03-01 | -$837.20M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-09-26 | $43.70M 10-Q · filed 2015-11-02 | -$911.50M derived: sum of 2 quarters · filed 2017-05-22 | -$942.50M 10-Q/A · filed 2017-05-23 | -$941.50M 10-Q · filed 2016-11-10 | $1.63B derived: sum of 4 quarters · filed 2017-05-22 | |||
| 2015-06-27 | -$955.20M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | -$986.80M 10-Q/A · filed 2017-05-22 | -$985.20M 10-Q · filed 2016-08-10 | $1.58B derived: sum of 3 quarters · filed 2017-05-22 | $1.52B 10-K · filed 2018-03-01 | $1.52B 10-K · filed 2015-08-13 | ||
| 2015-03-28 | -$31.60M 10-Q/A · filed 2017-05-22 | $2.54B derived: sum of 2 quarters · filed 2017-05-22 | $2.48B 10-Q · filed 2015-04-29 | $2.43B derived: sum of 4 quarters · filed 2017-05-22 | ||||
| 2014-12-27 | $2.57B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | $2.51B 10-Q · filed 2015-02-05 | $2.46B derived: sum of 3 quarters · filed 2017-05-22 | $2.41B derived: sum of 4 quarters · filed 2017-05-22 | ||||
| 2014-09-27 | -$61.30M 10-Q · filed 2015-11-02 | -$108.20M derived: sum of 2 quarters · filed 2017-05-22 | -$155.70M derived: sum of 3 quarters · filed 2017-05-22 | $995.50M derived: sum of 4 quarters · filed 2017-05-22 | ||||
| 2014-06-28 | -$46.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22 | -$94.40M derived: sum of 2 quarters · filed 2017-05-22 | $1.06B derived: sum of 3 quarters · filed 2017-05-22 | $1.03B 10-K · filed 2017-05-22 | ||||
| 2014-03-29 | -$47.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | $1.10B derived: sum of 2 quarters · filed 2015-04-29 | $1.07B 10-Q · filed 2015-04-29 | $1.66B derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-28 | $1.15B derived: 10-Q 6 month − 8-K 3 month · filed 2015-02-05 | $1.12B 10-Q · filed 2015-02-05 | $1.71B derived: sum of 3 quarters · filed 2016-02-25 | $1.70B derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-09-28 | -$28.80M 8-K · filed 2014-11-20 | $556.50M derived: sum of 2 quarters · filed 2016-02-25 | $550.70M derived: sum of 3 quarters · filed 2016-02-25 | |||||
| 2013-06-29 | $585.30M derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25 | $579.50M derived: sum of 2 quarters · filed 2016-02-25 | $577.20M 10-KT · filed 2016-02-25 | |||||
| 2013-03-30 | -$5.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | -$8.10M 10-Q · filed 2014-05-07 | ||||||
| 2012-12-29 | -$2.30M 10-Q · filed 2014-02-06 | |||||||
| 2012-06-30 | $458.70M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |